Finished product reference
Artificial Tears
Solution · Ophthalmic · 3.2 mg/1mL · 0.5 mL
- List code
- 50429
- Pharmacologic class
- Plasma Volume Expander
What it is and how it works
Mechanism class: Osmotic Activity
Indications
Uses For the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun May be used as a protectant against further irritation
Dosage and administration (summary)
Directions Shake well before use Instill 1 or 2 drops in the affected eye(s) as needed
Warnings and precautions
Warnings For use in the eyes only
Storage and supply
Other Information store at room temperature
Source: Artificial Tears (Artificial Tears) — US FDA prescribing information, 2026-07-07, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
- Gel · Ophthalmic · 0.2 % · 10 g50883
- Gel · Ophthalmic · 0.25 % · 0.5 g50308
- Gel · Ophthalmic · 0.25 % · 10 g50309
- Solution, Drops · Ophthalmic · 0.15 %/3 % · 10 mL52078
- Solution, Drops · Ophthalmic · 0.2 %/0.2 % · 0.5 mL51905
- Solution, Drops · Ophthalmic · 0.2 %/0.2 % · 10 mL51906
- Solution, Drops · Ophthalmic · 0.15 % · 0.35 mL51900
- Solution, Drops · Ophthalmic · 0.15 % · 0.5 mL52909
- Solution, Drops · Ophthalmic · 0.15 % · 10 mL52910
- Solution, Drops · Ophthalmic · 0.2 %51703
- Solution, Drops · Ophthalmic · 0.3 % · 0.35 mL51990
- Solution, Drops · Ophthalmic · 0.4 % · 0.5 mL51904
- Solution, Drops · Ophthalmic · 0.4 % · 10 mL51907
- Solution, Drops · Ophthalmic · 0.5 % · 15 mL52004
- Gel · Ophthalmic · 0.2 % · 10 g19130
- Solution · Ophthalmic · 3.2 mg/1mL · 10 mL51057
- Solution, Drops · Ophthalmic · 0.3 % · 0.5 mL51892
- Solution, Drops · Ophthalmic · 0.3 % · 10 mL51891
- Solution, Drops · Ophthalmic · 14 mg/1mL · 10 mL50647
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.